To include your compound in the COVID-19 Resource Center, submit it here.

GRO Biosciences launches with $2.1M seed funding

Synthetic protein newco GRO Biosciences Inc. (Boston, Mass.) raised $2.1 million on Sept. 28 in a seed round led by Digitalis Ventures

Read the full 221 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE